Plain-English translation of NCT06957314 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to deliver cancer care called Hospital-at-Home. Instead of going to a hospital to receive tarlatamab (a medication for advanced small-cell lung cancer), some patients will receive the medication at home while a medical team monitors their health remotely. The study wants to see if this approach works as well as traditional hospital-based treatment while making it more convenient for patients.
Receiving cancer treatment often requires frequent hospital visits, which can be difficult and stressful for patients. This trial is exploring whether the same medication can be safely given at home with remote monitoring, potentially making treatment easier and less disruptive to daily life.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll be randomly assigned to either receive your medication through the traditional hospital-based approach or through the Hospital-at-Home program. In the Hospital-at-Home arm, you'll receive the medication at home (or at designated housing) while trained medical staff monitor your health through remote check-ins and visits from community paramedics. Your caregiver will stay with you during this time to provide support and help with daily activities. The study will compare how well both approaches work and how they affect your quality of life.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States